Liberty Health Sciences Inc. (OTC: LHSIF) announced on May 11th that it will be adding Solei Sungrown Cannabis (Solei) to the company’s offered products portfolio. The company signed an amended licensing agreement with Aphria Inc. (OTC: APHQF), the owner of the Solei brand, to produce and sell Solei in the United States.
Liberty Health has its sights on producing and selling Solei in Florida and Massachusetts after it receives all proper approvals from the respective state governments.
The company will need approval from both the Florida Department of Health and the Office of Medical Marijuana Use to legally cultivate and sell Solei in Florida.
In Massachusetts the company will need approvals from the Commonwealth of Massachusetts and either its Medical Use of Marijuana Program or the Massachusetts Cannabis Control Commission.
The Solei brand will be sold in these states in a wide range of product options with simplistic instructions on all of the products available.
On the date of this announcement LHSIF value increased by 4.69% just before the market closed its regular hours. The value of APHQF stock also increased on May 11th by 2.76%.